Comprehensive Analysis of Federal Form 6765 as the Mandatory Compliance Nexus for the Delaware R&D Tax Credit

I. Executive Summary: The Mandate of Federal Form 6765 in Delaware Compliance

Federal Form 6765 (Credit for Increasing Research Activities) is the mandatory federal reporting schedule that substantiates a taxpayer’s Qualified Research Expenses (QREs) and establishes eligibility for the R&D credit.

It serves as the required bedrock documentation for all Delaware state R&D tax credit claims and provides the direct data input necessary for calculating the state credit under Method B.

The requirement by the Delaware Division of Revenue (DOR) to attach Federal Form 6765 to the state application Form 2070AC, Application and Computation Schedule for Claiming Delaware Research and Development Tax Credits, creates a mandatory link between federal tax compliance (Internal Revenue Code, or IRC, Section 41) and state incentive utilization.1 This document, whose purpose is to figure and claim the credit for increasing research activities federally 3, serves a critical dual function in Delaware.

First, Form 6765 acts as universal proof of eligibility for Qualified Research Expenses (QREs) regardless of which calculation method (Method A or Method B) the taxpayer chooses for the state credit. Delaware’s statute requires that activities must qualify for the federal R&D credit to be eligible for the state credit.2 By mandating the attachment of the federal form, the state effectively delegates the complex technical substantiation of the QREs to the federal framework. The federal credit requires taxpayers to meet stringent criteria, including the Four-Part Test (Permitted Purpose, Elimination of Uncertainty, Process of Experimentation, Technological in Nature).2 By requiring the Form 6765 attachment, the state implicitly accepts that the expenses reported have satisfied the primary, complex technical eligibility standards set by the IRS.

Second, for taxpayers electing Method B, the federal form serves as the non-negotiable data source for calculating the Delaware credit. Method B relies on the federal Alternative Simplified Credit (ASC) amount calculated on Form 6765.1 The requirement to attach the federal form efficiently exports the most resource-intensive portion of tax credit verification to the federal level. If the IRS were to later audit and disallow the QREs reported on Form 6765, the foundational eligibility for the corresponding Delaware claim would be automatically undermined. This regulatory linkage allows the DOR to focus its limited compliance resources primarily on confirming accurate apportionment—that is, verifying that the claimed QREs were physically conducted within Delaware—rather than re-litigating the complex technical qualification of the research activities themselves.

Finally, for taxpayers filing a consolidated corporate income tax return federally, the DOR imposes a crucial administrative requirement: the submission must include a proforma Form 6765 specific to the corporate applicant.1 This ensures that QREs and base calculations are accurately isolated for the specific entity claiming the Delaware credit, a necessary step since Delaware assesses corporate tax liability and credits based on the individual entity’s operations within the state.

II. The Foundational Framework of the Federal R&D Tax Credit

2.1. Purpose and Scope of IRS Form 6765

Federal Form 6765, officially titled Credit for Increasing Research Activities, is the dedicated schedule mandated under IRC Section 41 for taxpayers to compute and claim the federal R&D tax credit.3 Its presence is central to establishing the validity of a Delaware state claim.

The form details the Qualified Research Expenses (QREs)—including wages, supplies, and contract research expenses—incurred during the tax year. It facilitates the calculation of the credit amount using one of the three available federal methodologies: the Regular Credit, the Alternative Incremental Credit (AIC), or the Alternative Simplified Credit (ASC). The final calculated federal credit amount is then carried over to the taxpayer’s primary federal tax return.3

Form 6765 also serves as the necessary documentation platform for reporting critical federal elections that shape the treatment of QREs across all jurisdictions. Specifically:

• IRC Section 280C Election (Item A): Taxpayers must indicate at the top of Form 6765 whether they elect the reduced credit under Section 280C.3 This election is made on the original, timely filed return and prevents the taxpayer from having to reduce the deduction taken for QREs on the federal income statement.
• Controlled Group Reporting (Item B): If the taxpayer is a member of a controlled group or business under common control, Item B requires an affirmative indication and mandates an attachment detailing the allocation and aggregation of QREs within the group.3 This federal provision directly informs and justifies Delaware’s subsequent requirement for proforma reporting in consolidated filings.

2.2. Defining Qualified Research Expenses (QREs)

Delaware’s R&D tax credit structure is built directly upon the definitions established in IRC § 41.2 This harmonization of definitions ensures that any activity recognized as qualified research at the federal level automatically qualifies for the Delaware credit, provided the activity was conducted within the state’s borders.5

QREs principally include:

1. Wages paid to employees engaged in qualified research.
2. Costs of supplies used or consumed during the qualified research process.
3. Sixty-five percent (65%) of contract research expenses paid to third parties for qualified research.2

For these expenses to qualify, the underlying activities must satisfy the rigorous federal four-part quality test. The activity must be intended to discover information that eliminates uncertainty regarding the capability, method, or appropriateness of the design of a business component, and must constitute a systematic process of experimentation.2 The submission of Form 6765 confirms, in principle, that these high standards have been met for the reported QREs.

2.3. Consistency in Expense Treatment

The decision made by the taxpayer regarding the Section 280C election, as documented on Form 6765, establishes a fundamental choice about the financial treatment of the underlying research expenditures. Electing the reduced credit under 280C affects the taxpayer’s overall federal income tax liability by adjusting the deduction taken for QREs.

While the Delaware credit itself operates independently and is fully refundable (meaning it decouples the state benefit from state tax liability), the Division of Revenue expects to see consistency in the foundational expense treatment presented by the attached Form 6765. The federal election reflects a core strategic decision concerning the utilization of the research expenditures, and the state review process relies on the figures reported on the federal form for integrity and consistency when calculating the apportioned Delaware benefit.

III. Delaware Statutory Requirements and Eligibility Prerequisites

3.1. Delaware’s Legislative Authority and Application Process

The legal foundation for the Delaware Research and Development Tax Credit is codified in Title 30, Chapter 20, Subchapter VIII, specifically beginning with § 2070 of the Delaware Code.7

To claim the credit, taxpayers must complete and submit Delaware Form 2070AC, Application and Computation Schedule for Claiming Delaware Research and Development Tax Credits.1 The application must be completed and submitted to the Delaware Division of Revenue (DOR) no later than September 15th after the close of the taxable year during which the Qualified Research and Development Expenses were incurred.1 After review and approval by the DOR, the final approved credit amount is formally transferred via Delaware Form 2071AC.6

3.2. Mandatory Federal Eligibility and State Apportionment

The Delaware statute establishes a clear prerequisite: a business must be eligible to claim the federal R&D tax credit under IRC § 41 to qualify for the Delaware credit.2 Thus, without the demonstration of federal eligibility via Form 6765, the Delaware claim is invalid ab initio.

Beyond federal eligibility, the key requirement for state compliance is apportionment. Taxpayers must determine the portion of the federally eligible QREs that were attributable to research activities physically conducted within the State of Delaware. These are referred to as Delaware Qualified Research Expenses (DQREs).5 This location-specific expense determination is necessary for calculating both Method A (excess QREs) and Method B (apportioned ASC).

3.3. Policy Enhancements: Refundability and Cap Elimination

The Delaware R&D tax credit is notable for offering significant policy advantages that enhance its value, particularly for high-growth, technology-focused companies. Prior to 2017, the credit was limited in value to 50% of the tax liability imposed in the year, and there was an annual statewide cap of $5 million for all applicants combined.8 If total applications exceeded the cap, credits were prorated among eligible applicants.1

Recent legislation, effective January 1, 2017, removed both of these major limitations.8

• Full Refundability: The credit is now fully refundable. If the approved credit amount exceeds the taxpayer’s qualified tax liability for the year, the unused remainder is paid out as a cash refund.5 This feature transforms the Delaware credit into a non-dilutive source of capital, critically benefiting startup companies that are generating significant QREs but have not yet achieved profitability.8
• Elimination of Proration Risk: With the removal of the $5 million statewide cap, companies now receive 100 percent of their calculated and approved credit.5 This elimination of uncertainty provides greater strategic assurance for businesses planning large-scale research investments in the state.

The combination of full refundability and generous small business rates (up to 20% under Method A and 100% apportionment under Method B) significantly strengthens Delaware’s attractiveness as a hub for research activity. By providing immediate cash flow back to pre-profit companies incurring substantial qualified research expenditures, the tax code functions as a powerful, targeted mechanism to foster and sustain R&D jobs within the state.

IV. Delaware Division of Revenue (DOR) Guidance and Form 6765 Compliance Requirements

The instructions for Delaware Form 2070AC contain explicit, non-negotiable compliance requirements regarding Federal Form 6765, particularly focusing on the administrative details necessary for complex filers.

4.1. Universal Attachment Requirement

The Delaware Division of Revenue mandates that a copy of Federal Form 6765 must be attached to every submission of Form 2070AC.1 This requirement applies regardless of the state calculation method chosen (Method A or B), solidifying Form 6765’s role as the threshold documentation for QRE substantiation.2 The DOR uses this attachment to verify the basic structure of the taxpayer’s federal claim, confirming the reported QRE totals and the elections made (e.g., the Section 280C election).

4.2. Nuance for Consolidated Corporate Filers: The Proforma Mandate

For entities that are part of a larger controlled group and participate in a consolidated federal corporate income tax return, the DOR issues a highly specific instruction:

“IF A CONSOLIDATED CORPORATE INCOME TAX RETURN IS FILED, PLEASE ATTACH A PROFORMA FORM 6765 FOR THE CORPORATE APPLICANT.” 1

This directive is critical for multi-entity compliance. A consolidated federal Form 6765 reports QREs and the credit calculation for the entire controlled group. However, for state tax purposes, Delaware requires the calculation of corporate tax liability and credits based on the activities and apportionment factors of the individual corporate entity operating within the state.

The proforma submission isolates the data specific to the corporate applicant entity. It ensures that the QREs, base calculation, and federal ASC input (if Method B is chosen) are accurately delineated and verifiable for the specific entity claiming the Delaware credit. Failure to attach a proper proforma Form 6765 when filing a consolidated return is an administrative error that is highly likely to lead to the rejection of the Delaware R&D credit application due to non-compliance with the explicit documentation mandate.

This proforma requirement serves as a vital protective mechanism for Delaware’s tax base. It prevents tax avoidance strategies that could involve the inappropriate shifting or aggregation of QREs among related entities operating in different states. By demanding an isolated, entity-specific calculation, the DOR ensures that the federal eligibility is correctly attributed at the local level and that the state credit is claimed only against QREs properly attributable to the Delaware entity.

V. Detailed Analysis of Delaware Calculation Methods

The Delaware R&D tax credit statute permits taxpayers to choose annually between two distinct calculation methodologies.7 This election is independent of the method used to compute the federal R&D credit.1

5.1. Method A: Traditional Calculation Based on Excess QREs

Method A uses an incremental approach, providing a credit based on the amount by which current-year Delaware QREs exceed a historical base amount.

• Standard Rate: The credit is calculated as 10% of the excess of the taxpayer’s total Delaware qualified research and development expenses (DQREs) for the taxable year over the taxpayer’s Delaware base amount.5
• Small Business Rate: For small businesses—defined as any taxpayer with average annual gross receipts not exceeding $20,000,000 5—the credit rate is significantly enhanced, substituting “20%” for “10%”.5

The Method A computation steps require historical data to determine the Delaware Base Amount (DBA). The DBA is calculated by multiplying the Delaware Fixed Based Percentage (DFBP) by the average annual gross receipts for the four years preceding the credit year.1 Furthermore, the statute imposes a floor: the DBA cannot be less than 50% of the current year’s DQREs.5

5.2. Method B: The Alternative Simplified Credit (ASC) Approach

Method B ties the state credit directly to the federal R&D credit calculated using the Alternative Simplified Credit (ASC) method under IRC Section 41(c)(5).7 This approach simplifies the base calculation and is often advantageous for businesses with variable research spending or limited historical data.5 Method B provides the clearest illustration of the necessary data integration from Federal Form 6765.

The Role of Federal Form 6765 Data in Method B

The calculation for Method B, detailed in Form 2070AC, is executed as follows 1:

1. Federal ASC Input: The calculation begins by taking the Federal Alternative Incremental Credit amount reported on Line 39 of Federal Form 6765.1
2. Apportionment Basis: Since the federal credit is based on Total QREs (TQREs) nationwide (found on Line 48 of Form 6765 3), the federal credit must be apportioned to Delaware. This is accomplished by multiplying the Federal ASC amount by the ratio of DQREs (Delaware qualified research expenses) to TQREs (Total qualified research expenses).1
3. Delaware Credit Rate:

• Standard Rate: The final Delaware credit is 50% of the Delaware’s apportioned share of the federal ASC amount.5
• Small Business Rate: For qualifying small businesses, the rate is increased to 100% of Delaware’s apportioned share of the federal ASC amount.5

The most potent incentive for small, multi-state research businesses is found under Method B. The application of the 100% rate means that Delaware effectively matches the full federal ASC benefit proportionate to the research activity conducted within the state. This makes Method B a significantly lucrative choice for qualifying small taxpayers.

Table 1 summarizes the calculation parameters for the Delaware R&D credit.

Table 1: Summary of Delaware R&D Credit Calculation Methods

VI. Strategic Planning and Calculation Example

6.1. Optimization in Method Selection

Taxpayers should conduct annual projections to compare the outcomes of Method A and Method B. The optimal method is highly dependent on the taxpayer’s historical financial profile and QRE growth rate:

• High Growth: Method A may be superior if the taxpayer has significantly lower QREs and gross receipts in the four preceding years, resulting in a low base amount and a large “excess” QRE calculation.5
• Volatility or New Filers: Method B (ASC) simplifies the historical requirement and can be more predictable for companies with fluctuating QREs or those that lack comprehensive historical data.5
• Small Business Advantage: Given the 100% apportionment rate under Method B for small businesses, this option frequently generates a higher benefit than the 20% rate offered by Method A.5

6.2. Compliance Example: Calculation Flow for Method B

This example demonstrates the indispensable role of Federal Form 6765 data in generating the final Delaware R&D credit under Method B, using the advantageous small business rates.

Scenario Parameters:

• Taxpayer: A software development company classified as a Small Business (Gross Receipts < $20M).
• Total Qualified R&D Expenses (TQREs) (Reported on Federal Form 6765): $\$1,000,000$
• Delaware Qualified R&D Expenses (DQREs): $\$400,000$
• Federal Alternative Incremental Credit (Calculated on Form 6765, Line 39): $\$95,000$

Table 2: Calculation Flow for Delaware R&D Credit, Method B (Small Business Example)

The resultant Delaware R&D Tax Credit of $\$38,000$ would be fully refundable to the small business.

6.3. Audit Focus: Substantiating Delaware QREs

While Federal Form 6765 validates the national eligibility of the QREs (TQREs), the specific integrity of the Delaware claim rests heavily on the quality of documentation supporting the Delaware QREs (DQREs). As demonstrated by the Method B calculation (Table 2), the DQREs determine the critical apportionment ratio (Line 4).1

If the DOR accepts the technical qualification established by the attached Form 6765, the primary compliance risk and subsequent audit focus shift to verifying the location and attribution of research expenses. Taxpayers must maintain meticulous, location-specific cost segregation records—such as detailed payroll journals showing time spent in Delaware, geographically segregated vendor invoices for supplies used in the state, and contract research agreements clearly detailing the place of performance. This detailed, location-based substantiation is necessary to prove the accuracy of the DQRE numerator used in the state apportionment formula, which determines the final, refundable credit amount.

VII. Conclusion

Federal Form 6765 is not merely a supplementary schedule but a central pillar of Delaware R&D tax credit compliance. It establishes the mandatory federal nexus for eligibility under IRC § 41 and directly provides the necessary computational inputs for Delaware’s Method B calculation.

For the Delaware Division of Revenue, the mandatory attachment of Form 6765 streamlines administrative oversight by allowing the state to rely on the federal government’s detailed process for substantiating the fundamental technical eligibility of research expenses. This reliance allows Delaware’s tax enforcement efforts to concentrate on verifying the accurate apportionment of those QREs to in-state activities.

For multi-entity organizations, strict adherence to the DOR’s requirement for a proforma Federal Form 6765 is essential. This crucial administrative step ensures that the calculation is performed on an entity-specific basis, thereby correctly attributing QREs only to the corporate applicant and preventing the improper shifting of research costs across state lines.

Given the significant benefits offered by the modern Delaware R&D tax credit—including the elimination of the statewide cap and the full refundability of the credit since 2017—the incentive is one of the most valuable mechanisms for supporting innovation and providing cash flow to research-intensive businesses. Maximizing this benefit necessitates flawless adherence to the documentation requirements, starting with the timely and accurate submission of Federal Form 6765 or its proforma equivalent, providing a verifiable and auditable basis for the state credit claim.

R&D Tax Credit Preparation Services

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.

If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.

R&D Tax Credit Audit Advisory Services

creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.

Our Fees

Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/